# Identification of Prognostic Biomarkers for Progression of Invasive Squamous Cell Carcinoma

> **NCT02549638** · — · TERMINATED · sponsor: **Mayo Clinic** · enrollment: 22 (actual)

## Conditions studied

- Carcinoma, Squamous Cell
- Carcinoma, Squamous
- Squamous Cell Carcinoma
- Lung Neoplasms
- Cancer of Lung
- Cancer of the Lung
- Lung Cancer
- Neoplasms, Lung
- Neoplasms, Pulmonary
- Pulmonary Cancer
- Pulmonary Neoplasms

## Interventions

- **GENETIC:** DNA Extraction

## Key facts

- **NCT ID:** NCT02549638
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2015-04-08
- **Primary completion:** 2020-04-23
- **Final completion:** 2020-04-23
- **Target enrollment:** 22 (ACTUAL)
- **Why stopped:** Lack of funding, slow accrual
- **Last updated:** 2025-10-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02549638

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02549638, "Identification of Prognostic Biomarkers for Progression of Invasive Squamous Cell Carcinoma". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02549638. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*